Home > Qtrly Results > ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES
Quarterly Results Analysis [Dec2025]

ZYDUS LIFESCIENCES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

ZYDUS LIFESCIENCES Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹6,865 Cr ₹6,123 Cr ₹6,574 Cr ₹6,528 Cr ₹5,269 Cr ₹5,237 Cr ₹6,208 Cr ₹5,534 Cr
Expenses ₹5,048 Cr ₹4,522 Cr ₹4,542 Cr ₹4,402 Cr ₹3,882 Cr ₹3,821 Cr ₹4,124 Cr ₹3,909 Cr
Operating Income ₹1,816 Cr ₹1,602 Cr ₹2,031 Cr ₹2,126 Cr ₹1,388 Cr ₹1,416 Cr ₹2,084 Cr ₹1,625 Cr
Other Income ₹111 Cr ₹523 Cr ₹212 Cr ₹81 Cr ₹58 Cr ₹114 Cr ₹63 Cr ₹162 Cr
Interest ₹130 Cr ₹101 Cr ₹85 Cr ₹77 Cr ₹32 Cr ₹25 Cr ₹32 Cr ₹35 Cr
Depreciation ₹360 Cr ₹302 Cr ₹238 Cr ₹238 Cr ₹229 Cr ₹234 Cr ₹215 Cr ₹205 Cr
Profit Before Tax ₹1,353 Cr ₹1,687 Cr ₹1,921 Cr ₹1,672 Cr ₹1,184 Cr ₹1,271 Cr ₹1,900 Cr ₹1,547 Cr
Profit After Tax ₹965 Cr ₹1,233 Cr ₹1,487 Cr ₹1,249 Cr ₹1,005 Cr ₹898 Cr ₹1,464 Cr ₹1,226 Cr
EPS ₹10.36 ₹12.51 ₹14.58 ₹11.64 ₹10.17 ₹9.06 ₹14.11 ₹11.75
Industry Peers & Returns1W1M1Y
ZYDUS LIFESCIENCES 0.1% 2.9% -2.5%
SUN PHARMACEUTICAL INDUSTRIES 0.9% 6.2% 0.6%
DIVIS LABORATORIES 1.8% 4.8% 6.3%
CIPLA -1.3% 0.9% -8.9%
TORRENT PHARMACEUTICALS 1.3% 9.8% 37.7%
DR REDDYS LABORATORIES 1.7% 5.8% 6.7%
MANKIND PHARMA -0.9% -2.7% -13.6%
LUPIN -0.1% 5.1% 9.6%
AUROBINDO PHARMA -2.9% 1.5% -0.9%

ZYDUS LIFESCIENCES Quarterly Revenues

Revenues
Q-o-Q

12.11 %

Y-o-Y

30.28 %

Quarters Revenues % Change
Dec2025 ₹6,865 Cr
12.11
Sep2025 ₹6,123 Cr
-6.85
Jun2025 ₹6,574 Cr
0.70
Mar2025 ₹6,528 Cr
23.89
Dec2024 ₹5,269 Cr
0.61
Sep2024 ₹5,237 Cr
-15.63
Jun2024 ₹6,208 Cr
12.17
Mar2024 ₹5,534 Cr -

ZYDUS LIFESCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

13.40 %

Y-o-Y

30.90 %

Quarters Operating Profit % Change
Dec2025 ₹1,816 Cr
13.40
Sep2025 ₹1,602 Cr
-21.15
Jun2025 ₹2,031 Cr
-4.43
Mar2025 ₹2,126 Cr
53.18
Dec2024 ₹1,388 Cr
-2.01
Sep2024 ₹1,416 Cr
-32.05
Jun2024 ₹2,084 Cr
28.23
Mar2024 ₹1,625 Cr -
Operating Margins
Q-o-Q

1.15 %

Y-o-Y

0.49 %

Quarters Operating Margin% % Change
Dec2025 26.46%
1.15
Sep2025 26.16%
-15.34
Jun2025 30.9%
-5.10
Mar2025 32.56%
23.66
Dec2024 26.33%
-2.63
Sep2024 27.04%
-19.45
Jun2024 33.57%
14.30
Mar2024 29.37% -

ZYDUS LIFESCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-21.75 %

Y-o-Y

-3.93 %

Quarters Profit After Tax % Change
Dec2025 ₹965 Cr
-21.75
Sep2025 ₹1,233 Cr
-17.03
Jun2025 ₹1,487 Cr
19.04
Mar2025 ₹1,249 Cr
24.31
Dec2024 ₹1,005 Cr
11.90
Sep2024 ₹898 Cr
-38.66
Jun2024 ₹1,464 Cr
19.40
Mar2024 ₹1,226 Cr -
PAT Margins
Q-o-Q

-30.19 %

Y-o-Y

-26.27 %

Quarters PAT Margin(%) % Change
Dec2025 14.06 %
-30.19
Sep2025 20.14 %
-10.92
Jun2025 22.61 %
18.19
Mar2025 19.13 %
0.31
Dec2024 19.07 %
11.26
Sep2024 17.14 %
-27.31
Jun2024 23.58 %
6.46
Mar2024 22.15 % -

ZYDUS LIFESCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-17.19 %

Y-o-Y

1.87 %

Quarters EPS % Change
Dec2025 ₹10.36
-17.19
Sep2025 ₹12.51
-14.20
Jun2025 ₹14.58
25.26
Mar2025 ₹11.64
14.45
Dec2024 ₹10.17
12.25
Sep2024 ₹9.06
-35.79
Jun2024 ₹14.11
20.09
Mar2024 ₹11.75 -

You may also like the below Video Courses